BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, April 13, 2026
Home
»
Topics
» Cancer, BioWorld Science
Cancer, BioWorld Science
RSS
In vitro and in vivo activity against hepatocellular cancer seen with CUDC-101
May 7, 2008
MDV-3100 well tolerated, reduces PSA in castration-resistant prostate cancer patients
May 7, 2008
Cell Therapeutics changes brand name of Xyotax to Opaxio
May 6, 2008
Amgen presents a novel c-Met inhibitor with antitumor activity in vivo
May 6, 2008
Proteolix initiates phase II clinical trial of carfilzomib for relapsed solid tumors
May 6, 2008
NCI initiates phase I trial of Dusa's Levulan PDT in oral precancerous lesions
May 6, 2008
Cell sensitization with KU-0060648 improves DNA damaging anticancer therapy
May 6, 2008
Progress seen in development of MEK inhibitors from Ardea Biosciences
May 6, 2008
DMS-3008 tested against lung, head and neck cancer in vitro and in vivo
May 6, 2008
Further data on tubulin inhibitor LP-261 available
May 6, 2008
Previous
1
2
…
2428
2429
2430
2431
2432
2433
2434
2435
2436
…
3678
3679
Next
RSS